Myriad Genetics, a leader in molecular diagnostic testing and precision medicine, closed a five-year senior secured term loan credit facility providing up to $200 million of capital from OrbiMed, a leading global healthcare investment firm. The...
Read Story
August 04, 2025, 07:51 AM
|
Myriad Genetics, a leader in genetic testing and precision medicine, established a new $90 million asset-based credit facility with JPMorgan Chase Bank as administrative agent and issuing bank, and the other lender parties thereto consisting of Wells...
Read Story
July 07, 2023, 08:00 AM
|